ONG, KHYLE ADRIANNE L.

BSN 2 – A1

Name of
Drug Brand Dose, Frequency, Mechanism
Specific Indication Classification Side Effects Nursing Responsibilities
and Generic Route and Time of action
Name
Ceftriaxone Usual Dosage Treatment of PHARMACOTHERAPEUTIC: Binds to Discomfort with IM BASELINE ASSESSMENT: Obtain CBC,
(Generic Range IM/IV: susceptible Third generation bacterial cell administration, oral renal function test. Question for history
Name) ADULTS, ELDERLY: infections due to cephalosporin. membranes, candidiasis (thrush), of allergies, particularly cephalosporins,
1–2 g q12–24h. gram-negative inhibits cell mild diarrhea, mild penicillins.
CHILDREN: Mild to aerobic organisms, CLINICAL: Antibiotic. wall abdominal cramping,
Rocephin
moderate some gram-positive synthesis. vaginal candidiasis. INTERVENTION/EVALUATION: Assess
(Brand infection: 50–75 organisms, including Therapeutic Occasional: Nausea, oral cavity for white patches on mucous
Name) mg/kg/day in 1–2 respiratory tract, Effect: serum sickness–like membranes, tongue (thrush). Monitor
divided doses. GU tract, skin and Bactericidal. reaction (fever, joint daily pattern of bowel activity, stool
Maximum: 1 skin structure, bone pain; usually occurs consistency. Mild GI effects may be
g/day. Severe and joint, intra- after second course of tolerable (increasing severity may
infection: 100 abdominal, pelvic therapy and resolves indicate onset of antibiotic-associated
mg/kg/day divided inflammatory after drug is colitis). Monitor I&O, renal function
q12– 24h. disease (PID), biliary discontinued). Rare: tests for nephrotoxicity, CBC. Be alert
Maximum: 4 tract/urinary tract Allergic reaction (rash, for superinfection: fever, vomiting,
g/day. infections; bacterial pruritus, urticaria), diarrhea, anal/ genital pruritus, oral
NEONATES: 50 septicemia, thrombophlebitis mucosal changes (ulceration, pain,
mg/kg/dose given meningitis, (pain, redness, erythema).
once daily. Dosage perioperative swelling at injection
in Renal/Hepatic prophylaxis, acute site). PATIENT/FAMILY TEACHING
Impairment bacterial otitis • Discomfort may occur with IM
Dosage media. injection.
modification is • Doses should be evenly spaced.
usually OFF-LABEL: • Continue antibiotic therapy for full
unnecessary, but Complicated length of treatment.
hepatic/renal gonococcal
function test infections, STDs,
results should be Lyme disease,
monitored in pts salmonellosis,
with renal and shigellosis, atypical
hepatic community-
impairment or acquired
severe renal pneumonia.
impairment.